Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gainsharing Bill Could Be Introduced In Early 2006 – Staffer

This article was originally published in The Gray Sheet

Executive Summary

Gainsharing legislation could emerge from Congress before the end of the year or by early next year, according to a Republican congressional staffer

You may also be interested in...

Efficiency Standards Could Be As Troublesome As Gainsharing, AdvaMed Says

Physicians who prescribe more PET scans than their peers could be penalized if a provision buried in the Senate budget reconciliation bill becomes law, according to AdvaMed

Gainsharing Will Be Scrutinized At An Upcoming Ways & Means Hearing

House Ways & Means/Health Subcommittee Chair Nancy Johnson (R-Conn.) will convene a hearing on gainsharing Oct. 7

Big Win For EMA On Transparency

The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts